What is Righteye?
Founded in 2012 and headquartered in Bethesda, Maryland, Righteye, LLC operates at the intersection of health technology and vision performance. The company leverages advanced eye-tracking technology and gamified experiences to offer comprehensive vision tests and training programs. Righteye's proprietary EyeQ tests provide healthcare professionals with objective, metric-driven assessments of eyesight, brain function, reading disorders, and performance issues. Its cloud-based platform delivers rapid reports, enabling clinicians to monitor patient progress and treatment efficacy. The company's solutions cater to diverse sectors including sports, military, law enforcement, and general healthcare, aiming to enhance visual capabilities and identify neurological or reading-related challenges.
How much funding has Righteye raised?
Righteye has raised a total of $10.2M across 4 funding rounds:
Private Equity
$2.1M
Private Equity
$7.3M
Debt
$350K
Debt
$492K
Private Equity (2014): $2.1M, investors not publicly disclosed
Private Equity (2017): $7.3M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $492K featuring PPP
Key Investors in Righteye
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Righteye?
The recent major strategic investment signals a pivotal phase for Righteye, likely aimed at scaling its technological infrastructure, expanding market reach, and further developing its suite of vision assessment and training tools. With a foundation built on science-based methodologies and objective data, Righteye is well-positioned to capitalize on the growing demand for personalized health technology solutions. Future endeavors may include deeper integration into clinical workflows, broader adoption in performance-oriented industries, and continued innovation in diagnostic and therapeutic vision applications.
See full Righteye company page
